REG - Tristel PLC - Trading update <Origin Href="QuoteRef">TSTL.L</Origin>

TristelAnnouncement

15/07/2015 18:42

RNS Number : 8045N
Tristel PLC
21 May 2015
21 May 2015
Tristel plc
("Tristel" or the "Company")
Trading update
Tristel plc (AIM: TSTL), the manufacturer of infection prevention, contamination control and hygiene products provides a trading update for the year ending 30 June 2015.
Tristel addresses three distinct markets: Human Healthcare, Animal Healthcare and Contamination Control, with three distinctively branded product ranges: Tristel, Anistel and Crystel.
The Group has performed ahead of budget in both sales and profit terms over the ten months to 30 April 2015. The strong profit performance can be pinpointed to the Group's direct operations in the UK, Germany and Australasia. Amongst our direct operations, the only disappointing area has been Russia, where the Board continues to review its future prospects.
The Company has raised its internal expectations for the current financial year, and pre-tax profit (before share-based payments) is now expected to be not less than 2.5m (2014: 1.8m)
Paul Swinney, Chief Executive, comments "The sales momentum that has built within the business over the course of the past two and a half years is being maintained. Our cost base is well controlled and the organisation is dealing well with the execution of our growth strategy. All of this translates to a record profit to be reported for the year".
For further information please contact:
Tristel plc
www.tristel.com
Paul Swinney, Chief Executive Officer
Tel: 01638 721 500
Liz Dixon, Finance Director



Walbrook PR Ltd
Tel: 020 7933 8780 or tristel@walbrookpr.com
Paul McManus
Mob: 07980 541 893 
Lianne Cawthorne
Mob: 07854 391 303


finnCap
Tel: 020 7600 1658
Geoff Nash (Corporate Finance)

Charlotte Stranner (Corporate Finance)

Stephen Norcross (Corporate Broking)

This information is provided by RNS
The company news service from the London Stock Exchange
  END
MSCLBLFLEEFZBBK